Lung growth and development is complex and occurs throughout fetal life and into childhood. We work to reduce poor lung development because of potentially preventable prenatal or early childhood insults (e.g. tobacco exposure, malnutrition) and thus avoid respiratory symptoms and functional limitation later in life.
Consultancy and services
Catherine Molloy Catherine joined LSTM as the Programme Co-coordinator for the Experimental Pneumococcal Human Challenge Consortium (EHPC) Programme Grant in May 2015. Working closely with Professor Stephen Gordon and Daniela Ferreira Catherine co-ordinates...
Dr Derek Sloan Dr Sloan is an Infectious Diseases clinician who has worked in both high- and low-income countries, accruing extensive experience in the treatment of patients with complex infections, particularly tuberculosis (TB) and Human Immunodeficiency Virus...
Dr Andrea Collins Areas of interest: Pneumococcal infection and colonisation, bronchiectasis and research bronchoscopy and bronchoalveolar lavage.